Ledger.Open graph →
SEC Form D · filed November 24, 2023

Octave Bioscience Inc

Offering
$37.5M
Sold
$32.5M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
MENLO PARK, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Melinda Thomas · MENLO PARK, CAExecWilliam Hagstrom · MENLO PARK, CAExec · DirectorMichael Pellini · MENLO PARK, CADirectorBrook Byers · MENLO PARK, CADirectorAndrea Jackson · MENLO PARK, CADirectorA. Grant Heidrich Iii · MENLO PARK, CADirectorGeorge Scangos · MENLO PARK, CADirectorThomas Hawes · MENLO PARK, CADirectorJonathan D. Herpy · Wilmington, DEDirectorChristopher Mclaughlin · Chicago, ILExecDana Emberton · Greenville, SCDirectorKenton C. Leo · Lone Tree, COExec · DirectorClifford Pollard · Oakdale, CADirectorAngela J. Brau · Provo, UTDirectorJonathan Landsverk · Greenville, SCDirectorDerrin J. Hill · Provo, UTDirectorBobby Marhamat · San Francisco, CAExec · DirectorJack Abraham · San Francisco, CAExecTuan Ho · San Francisco, CADirectorLeo Polovets · San Francisco, CADirectorChad Byers · San Francisco, CADirectorBrandon Tseng · San Diego, CADirectorDaniel Gwak · San Diego, CADirectorPeter Levine · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗